Citations

Mayo Clinic

Clear

3501 citation(s) found for "Wu, Timothy".

Abstract 12116: Identifying the Underlying Causes of Unexplained Dyspnea at High Altitude Using Normobaric Hypoxia With Transthoracic Echocardiography
Barry, Timothy , Wraith, Rachel, Brown, Lisa , Radavich, Michael S., Curtisi, Pamela J., Hartzendorf, Patricia C., Lasota, Elizabeth M., Umetsu, Kyley N., Karlson, Kristin E., Breznak, BSN Karen K, Lester, Steven J., Stepánek, Jan , Mahmoud, Ahmed , Farina, Juan M. , Chao, Chieh‐Ju , Alsidawi, Said , Peterson, Jill M, Arsanjani, Reza

Circulation | December 19, 2023 | Volume: 148 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.148.suppl_1.12116 Get It

Introduction: Exposure to high altitude results in hypobaric hypoxia, leading to physiological changes in the cardiovascular system that may result in dyspnea. Hypoxic simulation testing (HSTs) simulates changes in physiology that occur at a specific altitude. Hypothesis: The use of transthoracic echocardiography (TTE) during HST can detect the raise in right-sided pressures revealing underlying causes of high-altitude dyspnea. Methods: We performed a prospective observational study of consecutive patients with unexplained dyspnea at high altitude who were referred to an aerospace medicine program at a single institution between August 2021 and March 2023. Reduced FiO 2 was administered for 20 minutes to simulate altitude levels specific to patients’ history. TTE images were obtained at baseline and during peak hypoxia to evaluate right ventricular (RV) function, RV systolic pressure, and any possible shunts. Result: The study included 27 patients, with a mean age of 64.7 ±14.4 years and 14 (51.9%) females. No significant abnormalities were seen on baseline TTE and no significant differences in blood pressure and heart rate between baseline and hypoxia simulation were detected. Notably, RV systolic pressure increased at peak hypoxia, while RV systolic function declined as shown by a decrease in S’ wave and TAPSE ( Figure 1 ). Additionally, right to left shunts were present in 19 (70.4%) patients. Of these, four patients (21.1%) had shunts present at baseline with no changes at peak hypoxia, while the severity of shunts increased at peak hypoxia in eight cases (42.1%) and the shunts were only evident during hypoxia in seven patients (36.8%). Conclusion: TTE during HST provides valuable information by revealing the presence of symptomatic, sustained shunts and confirming the decline in RV hemodynamics explaining dyspnea at altitude. Further studies are necessary to establish the optimal clinical role of this physiologic method.
Reply by Authors
Lyon, Timothy D. , Ugwuowo, Ugochukwu , Pollock, Benjamin D. , Ugwuowo, Ugochukwu C, Pollock, Benjamin D , Lyon, Timothy D

Journal of Urology | December 15, 2023 | Volume: 211 | Issue: 3 | Pages: 472-472

10.1097/ju.0000000000003795.02 | PMID 38100828 Get It

Oncologic Safety of Close Margins in Patients With Low- to Intermediate-Grade Major Salivary Gland Carcinoma
Sajisevi, Mirabelle , Nguyen, Kenny , Holcomb, Andrew J. , Vural, Emre , Davis, Kyle P. , Plonowska‐Hirschfeld, Karolina A. , Stein, John S. , Eskander, Antoine , Enepekides, Danny , Hier, Michael P. , Ryan, William R. , Section, American Head and Neck Society Salivary Gland, Aulet, Ricardo , Bell, Rebecca K. , Blasco, Michael A., Bowmaster, Vanessa B., Burruss, Clayton P. , Chung, Jeffson , Coffey, Charles S. , Cordero, Joehassin , Donovan, John, Du, Yue , Feinberg, Philip A. , Garvey, Emily A. , Goldstein, David P. , Goulart, Rafael Nunes, Grasl, Stefan , Giurintano, Jonathan P. , Hara, Jared H. , Hinni, Michael L., Hua, Nadia , Johnson‐Obaseki, Stephanie , Kalman, Noah S. , Khaja, Sobia F. , Ku, Jamie A., Lambert, Arnaud, Luu, Bao K. , Magliocca, Kelly R. , Santos, Luiz Roberto Medina dos , Michael, C. A., Miles, Brett A., Melo, Giulianno Molina de , Moore, Michael G. , Morand, Grégoire B. , Moura, Kauê, Mukdad, Laith , Noroozi, Hesameddin, Patel, Rusha , Paydarfar, Joseph A. , Savaria, Fabrice N., Shapiro, Justin , Stokes, William A. , Sulibhavi, Anita , Vendra, Varun , Vinh, Daniel , Virgen, Celina G. , Wooten, Christian , Woody, N.M. , Young, Geoffrey D., de Melo, Giulianno Molina , Morand, Gregoire B , CALLAS, PETER W. , Thomas, Carissa M. , Kakarala, Kiran , Section, American Head and Neck Society Salivary Gland, Asarkar, Ameya A , Chan, Kimberly , Chang, Brent A. , Cognetti, David M. , Cooper, Dylan Jacob , Donovan, John, Dundar, Yusuf , Dedivitis, Rogerio , Edwards, Heather , Erović, Boban M. , Goodman, Joseph , Goyal, Neerav , Gupta, Nikita , Habib, Andy , Hackman, Trevor , Henson, Christina , Juloori, Aditya , Kejner, Alexandra E , Michael, Cara, Sadeghi, Nader , Schmitt, Nicole C. , Shaver, Timothy B , Stoeckli, Sandro Johannes , John, Maie A. St. , Tasoulas, Jason

JAMA Otolaryngology–Head & Neck Surgery | December 14, 2023 | Volume: 150 | Issue: 2 | Pages: 107

10.1001/jamaoto.2023.3952 | PMID 38095911 Get It

ImportancePostoperative radiation therapy for close surgical margins in low- to intermediate-grade salivary carcinomas lacks multi-institutional supportive evidence.ObjectiveTo evaluate the oncologic outcomes for low- and intermediate-grade salivary carcinomas with close and positive margins.Design, Setting, and ParticipantsThe American Head and Neck Society Salivary Gland Section conducted a retrospective cohort study from 2010 to 2019 at 41 centers. Margins were classified as R0 (negative), R1 (microscopically positive), or R2 (macroscopically positive). R0 margins were subclassified into clear (>1 mm) or close (≤1 mm). Data analysis was performed from June to October 2023.Main Outcomes and MeasuresMain outcomes were risk factors for local recurrence.ResultsA total of 865 patients (median [IQR] age at surgery, 56 [43-66] years; 553 female individuals [64%] and 312 male individuals [36%]) were included. Of these, 801 (93%) had parotid carcinoma and 64 (7%) had submandibular gland carcinoma, and 748 (86%) had low-grade tumors and 117 (14%) had intermediate-grade tumors, with the following surgical margins: R0 in 673 (78%), R1 in 168 (19%), and R2 in 24 (3%). Close margins were found in 395 of 499 patients with R0 margins (79%), for whom margin distances were measured. A total of 305 patients (35%) underwent postoperative radiation therapy. Of all 865 patients, 35 (4%) had local recurrence with a median (IQR) follow-up of 35.3 (13.9-59.1) months. In patients with close margins as the sole risk factor for recurrence, the local recurrence rates were similar between those who underwent postoperative radiation therapy (0 of 46) or observation (4 of 165 [2%]). Patients with clear margins (n = 104) had no recurrences. The local recurrence rate in patients with R1 or R2 margins was better in those irradiated (2 of 128 [2%]) compared to observed (13 of 64 [20%]) (hazard ratio [HR], 0.05; 95% CI, 0.01-0.24). Multivariable analysis for local recurrence found the following independent factors: age at diagnosis (HR for a 10-year increase in age, 1.33; 95% CI, 1.06-1.67), R1 vs R0 (HR, 5.21; 95% CI, 2.58-10.54), lymphovascular invasion (HR, 4.47; 95% CI, 1.43-13.99), and postoperative radiation therapy (HR, 0.10; 95% CI, 0.04-0.29). The 3-year local recurrence-free survivals for the study population were 96% vs 97% in the close margin group.Conclusions and RelevanceIn this cohort study of patients with low- and intermediate-grade major salivary gland carcinoma, postoperative radiation therapy for positive margins was associated with decreased risk of local recurrence. In isolation from other risk factors for local recurrence, select patients with close surgical margins (≤1 mm) may safely be considered for observation.
Identification of Sleep Patterns via Clustering of Hypnodensities
Mirth, Joshua , Felton, Christopher L. , Haider, Clifton R. , Holmes, David R. , Felton, Christopher L , McCarter, Stuart J. , Morgenthaler, Timothy I. , Louis, Erik K. St. , Holmes, David R.

2023 45th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) | December 11, 2023 | Volume: No volume available | Issue: No issue available | Pages: 1-4

10.1109/embc40787.2023.10340905 | PMID 38083670 Get It

Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Kumar, Shaji , Adekola, Kehinde , Anderson, Larry D. , Costello, Caitlin, D’Angelo, Christopher R. , Elsedawy, Noura, Godby, Kelly, Hillengaß, Jens , Holmberg, Leona , Htut, Myo, Huff, Carol Ann , Hultcrantz, Malin , Larson, Sarah , Liedtke, Michaela , Omel, James, Robinson, Timothy, Sborov, Douglas W. , Valent, Jason , Varshavsky‐Yanovsky, Asya, Snedeker, Jenna, Holmberg, Leona , Anderson, Larry D , Callander, Natalie S. , Baljević, Muhamed , Baz, Rachid , Campagnaro, Erica , Castillo, Jorge J. , Costello, Caitlin , Devarakonda, Srinivas , Garfall, Alfred L. , Htut, Myo , Kang, Yubin , Lee, Hans C. , Martin, Thomas G. , Rosenberg, Aaron , Schroeder, Mark A. , Sherbenou, Daniel W , Suvannasankha, Attaya , Valent, Jason Neil , Kumar, Rashmi

Journal of the National Comprehensive Cancer Network | December 11, 2023 | Volume: 21 | Issue: 12 | Pages: 1281-1301

10.6004/jnccn.2023.0061 | PMID 38081133 Get It

The treatment of relapsed/refractory multiple myeloma (MM) has evolved to include several new options. These include new combinations with second generation proteasome inhibitors (PI); second generation immunomodulators, monoclonal antibodies, CAR T cells, bispecific antibodies, selinexor, venetoclax, and many others. Most patients with MM undergo several cycles of remissions and relapse, and therefore need multiple lines of combination therapies. Selecting treatment options for relapsed/refractory MM requires consideration of resistance status to specific classes, and patient-specific factors such as age and other comorbidities should be considered. The NCCN Guidelines for MM provide a framework on which to base decisions regarding workup, treatment, and follow-up of newly diagnosed and previously treated MM. This manuscript outlines the recommendations from NCCN Guidelines for MM specific to relapsed/refractory disease.
Towards a Lightweight Classifier to Detect Hypovolemic Shock
Pramanik, Leena , Felton, Christopher L. , Techentin, Robert W., Holmes, David R. , Joyner, Michael J. , Haider, Clifton R. , Joyner, Michael J , Felton, Christopher L , Curry, Timothy B. , Convertino, Víctor A.

2023 45th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) | December 11, 2023 | Volume: No volume available | Issue: No issue available | Pages: 1-5

10.1109/embc40787.2023.10340949 | PMID 38083358 Get It

Mitigating Fracture of the Acromion and Scapular Spine After Reverse Shoulder Arthroplasty
Buchanan, Timothy R. , Bindi, Victoria E. , Caban-Klepac, Ettienne , Hones, Keegan M. , Wright, Thomas W. , King, Joseph J. , Hao, Kévin A. , Schoch, Bradley S , King, Joseph J , Hao, Kevin A , Hones, Keegan M , Schoch, Bradley S.

JBJS Reviews | December 11, 2023 | Volume: 11 | Issue: 12 | Pages: No page available

10.2106/jbjs.rvw.23.00175 | PMID 38079495 Get It

» Biomechanical studies report that thin scapular spine (SS) morphology, superiorly placed glenoid components, and increased glenoid baseplate screws contribute to increased acromial and SS strain and may increase fracture risk. » Clinical risk factors of acromial and SS fractures after reverse shoulder arthroplasty include increasing age, female sex, osteoporosis, rheumatoid arthritis, thin midsubstance acromion morphology, previous acromioplasty, and surgical indication of cuff tear arthropathy. » Clinical studies show that, in isolation, excessive humeral lengthening, humeral lateralization, and glenoid medialization may increase risk of acromial and SS fractures. » Biomechanical studies suggest that a combination of glenoid medialization and humeral lateralization (MG/LH) may reduce fracture risk, although this requires clinical correlation. » Surgeons might reduce fracture risk in patients of high-risk groups by guarding against excessively lengthening the humerus, using a MG/LH prosthesis, and targeting screws to avoid the scapular notch and base of the SS. Level of Evidence: Level V . Narrative Review. See Instructions for Authors for a complete description of levels of evidence.
Patterns of Use and Safety of Newer Disease-modifying therapies in Pediatric Multiple Sclerosis in the US (S51.004)
Aaen, Gregory , Gorman, Mark , Harris, Yolanda, Lotze, Timothy , Mar, Soe , Moodley, Manikum , Rose, John , Schreiner, Teri , Waltz, Michael , Casper, T. Charles , Krysko, Kristen M. , Graves, Jennifer , Rensel, Mary R. , Benson, Leslie , Chitnis, Tanuja , Goyal, Manu S. , Krupp, Lauren , Rodriguez, Moses , Schreiner, Teri , Weinstock‐Guttman, Bianca , Waubant, Emmanuelle L.

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.s51.004 Get It

Progressive Motor Impairment from a Critically Located Lesion in Highly Restricted CNS Demyelinating Disease (P5.034)
Keegan, Mark , Weinshenker, Brian, Kantarci, Orhun H. , Schmalstieg, William F., Kaufmann, Timothy J. , Soldán, M. Mateo Paz , Flanagan, Eoin P.

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.p5.034 Get It